Suppr超能文献

用于软组织修复的纯化及低温灭菌可注射胶原蛋白的生物相容性研究:大鼠肌肉内植入

Biocompatibility Study of Purified and Low-Temperature-Sterilized Injectable Collagen for Soft Tissue Repair: Intramuscular Implantation in Rats.

作者信息

Koo Tae-Hoon, Lee Jason K, Grogan Shawn P, Ra Ho Jong, D'Lima Darryl D

机构信息

D.med LLC, 111, Sagimakgol-ro, Jungwon-gu, Seongnam-si 13202, Gyeonggi-do, Republic of Korea.

Shiley Center for Orthopaedic Research and Education at Scripps Clinic, 10666 N Torrey Pines Road, MS126, La Jolla, CA 92037, USA.

出版信息

Gels. 2024 Sep 26;10(10):619. doi: 10.3390/gels10100619.

Abstract

The clinical application of collagen-based biomaterials is expanding rapidly, especially in tissue engineering and cosmetics. While oral supplements and injectable skin boosters are popular for enhancing skin health, clinical evidence supporting their effectiveness remains limited. Injectable products show potential in revitalizing skin, but safety concerns persist due to challenges in sterilization and the risk of biological contamination. Traditional methods of sterilization (heat and irradiation) can denature collagen. This study addresses these issues by introducing a novel technique: the double filtration and low-temperature steam sterilization of a collagen gel. In vitro tests documented the sterility and confirmed that the collagen did not show cytotoxicity, degradation, integrity, and viscosity characteristics changes after the processing and sterilization. The collagen gel induced new collagen expression and the proliferation of human dermal fibroblasts when the cells were cultured with the collagen gel. An in vivo study found no adverse effects in rats or significant lesions at the implantation site over 13 weeks. These results suggest that this novel method to process collagen gels is a safe and effective skin booster. Advanced processing methods are likely to mitigate the safety risks associated with injectable collagen products, though further research is needed to validate their biological effectiveness and clinical benefits.

摘要

基于胶原蛋白的生物材料的临床应用正在迅速扩展,尤其是在组织工程和化妆品领域。虽然口服补充剂和可注射的皮肤增强剂因促进皮肤健康而广受欢迎,但支持其有效性的临床证据仍然有限。可注射产品在使皮肤恢复活力方面显示出潜力,但由于灭菌方面的挑战和生物污染风险,安全问题依然存在。传统的灭菌方法(加热和辐照)会使胶原蛋白变性。本研究通过引入一种新技术来解决这些问题:对胶原蛋白凝胶进行双重过滤和低温蒸汽灭菌。体外测试记录了无菌性,并证实胶原蛋白在加工和灭菌后未显示出细胞毒性、降解、完整性和粘度特性的变化。当细胞与胶原蛋白凝胶一起培养时,胶原蛋白凝胶诱导了新的胶原蛋白表达和人真皮成纤维细胞的增殖。一项体内研究发现,在13周的时间里,大鼠没有出现不良反应,植入部位也没有明显病变。这些结果表明,这种加工胶原蛋白凝胶的新方法是一种安全有效的皮肤增强剂。先进的加工方法可能会降低与可注射胶原蛋白产品相关的安全风险,不过还需要进一步研究来验证其生物学有效性和临床益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be0/11508103/ad283d666527/gels-10-00619-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验